当前位置:首页 - 行情中心 - 万孚生物(300482) - 财务分析 - 资产负债表

万孚生物

(300482)

  

流通市值:75.16亿  总市值:106.62亿
流通股本:3.33亿   总股本:4.72亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金732,820,331.181,043,005,370.22748,995,644.521,162,513,186.1
应收票据及应收账款568,798,836.62588,512,404.26566,469,666.95540,967,846.51
其中:应收票据1,517,3432,907,8682,017,395806,420
应收账款567,281,493.62585,604,536.26564,452,271.95540,161,426.51
预付款项27,866,299.1532,544,655.3739,547,066.9426,556,598.91
其他应收款合计75,275,033.3478,621,077.286,122,261.866,604,955.73
存货381,737,156.16415,731,044.29466,705,476.95399,967,713.19
一年内到期的非流动资产---200,260,486.11
其他流动资产18,854,407.1625,946,416.7523,361,256.8915,446,112.1
流动资产平衡项目0000
流动资产合计3,155,806,956.723,248,712,669.223,214,883,420.683,350,388,699
非流动资产:
债权投资211,872,602.75209,830,958.91413,344,195.21720,483,013.7
长期股权投资391,336,209.24392,877,832.39362,740,750.98363,517,813.72
其他权益工具投资203,070,000203,570,000200,570,000200,220,000
固定资产1,036,686,566.12977,327,951.72970,493,218.89963,804,740.63
在建工程250,806,489.97296,757,149.88270,525,935.89199,138,274.61
使用权资产49,911,470.3855,676,319.8620,162,744.3726,375,340.79
无形资产190,870,255.26197,961,961.9201,257,838.63203,711,426.11
开发支出69,750,299.3453,554,509.8549,977,100.6251,761,818.09
商誉115,371,168.89115,371,168.89115,371,168.89115,371,168.89
长期待摊费用12,443,761.913,319,277.6512,005,117.8413,275,218.63
递延所得税资产50,484,047.0749,765,560.2457,589,273.0753,685,619.57
其他非流动资产28,639,807.2430,297,748.828,835,035.539,405,364.32
非流动资产平衡项目0000
非流动资产合计2,611,242,678.162,596,310,440.092,702,872,379.892,950,749,799.06
资产平衡项目0000
资产总计5,767,049,634.885,845,023,109.315,917,755,800.576,301,138,498.06
流动负债:
短期借款--3,000,000204,357,852.72
交易性金融负债4,653,10015,638,10015,638,10015,638,100
衍生金融负债---250,816.3
应付票据及应付账款132,806,833.23166,123,754.78215,376,014.72320,075,579.83
应付账款132,806,833.23166,123,754.78215,376,014.72320,075,579.83
合同负债64,129,091.9362,191,407.6474,451,510.56236,314,787.16
应付职工薪酬42,994,759.1696,509,102.6673,366,252.27164,772,953.06
应交税费34,261,847.6540,291,264.2868,391,283.5286,502,219.89
其他应付款合计46,879,284.8954,287,623.957,516,119.0287,950,673.96
一年内到期的非流动负债21,603,925.4922,642,648.110,573,584.0616,864,376.93
其他流动负债549,940.92547,028.31,360,812.888,327,607.91
流动负债平衡项目0000
流动负债合计347,878,783.27458,230,929.66519,673,677.031,141,054,967.76
非流动负债:
应付债券546,092,868.71545,504,179.43539,027,522.55532,490,152.73
租赁负债30,040,084.9434,508,821.4311,269,104.7211,186,330.85
递延收益40,929,419.6941,523,200.9246,857,514.1923,095,073.06
递延所得税负债57,669,646.5356,162,451.1354,470,295.1955,754,198.82
非流动负债平衡项目0000
非流动负债合计674,732,019.87677,698,652.91651,624,436.65622,525,755.46
负债平衡项目0000
负债合计1,022,610,803.141,135,929,582.571,171,298,113.681,763,580,723.22
所有者权益(或股东权益):
实收资本(或股本)444,515,501444,514,936444,514,860444,514,668
其他权益工具107,491,436.03107,496,649.5107,497,368.6107,499,166.35
资本公积770,776,503.77770,749,673.91781,822,585.31775,525,079.56
减:库存股144,042,241.84113,945,863.25157,297,580.75157,297,580.75
其他综合收益10,112,458.659,808,295.118,286,972.027,895,644.8
盈余公积261,061,579.09261,061,579.09261,061,579.09261,061,579.09
未分配利润3,083,738,819.163,018,430,832.563,108,234,993.42,904,556,832.12
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计4,533,654,055.864,498,116,102.924,554,120,777.674,343,755,389.17
少数股东权益210,784,775.88210,977,423.82192,336,909.22193,802,385.67
股东权益平衡项目0000
股东权益合计4,744,438,831.744,709,093,526.744,746,457,686.894,537,557,774.84
负债和股东权益合计5,767,049,634.885,845,023,109.315,917,755,800.576,301,138,498.06
公告日期2023-10-262023-08-162023-04-262023-03-31
审计意见(境内)标准无保留意见
TOP↑